Articles written by Priya Nigam - Benzinga

This Wayfair Analyst Cuts Forecast After Workforce Reduction Announcement

|Wayfair shares fall after announcing workforce reduction due to technology replatforming. Analyst reaffirms Overweight rating.

This SentinelOne Analyst Cuts Forecast Ahead Of Q4; Projects Marginal Upside To ARR, Better Profitability

|SentinelOne Inc (NYSE: S) stock decreases ahead of earnings, expected to report higher NNARR and provide positive fiscal 2026 guidance according to JPMorgan analyst Brian Essex.

Costco Wholesale Posts Q4 Earnings Miss; Performing Well Above Peers, Analysts Say

|Costco shares down after reporting mixed Q2 results. Analysts optimistic about strong sales and potential growth.

Gap Continues To Grow Sales, Take Market Share, Analysts Say

|Gap's Q4 results beat expectations, with sales growth, gross margins, and earnings all exceeding consensus. JPMorgan analyst raises price target.

Kroger Posts Q4 Earnings Beat: Healthy ID Sales Overshadowed By Profit Constraints, Analysts Say

|KR stock rose after reporting upbeat Q4 earnings amid exciting season. Analysts see strong positioning & digital profitability for Kroger.

Foot Locker's Non-Nike Sales Hit 40%, Analysts Note Strong Shift

|Foot Locker (FL) shares down on weak Q4 sales, $300MM capex for 2025, and lower margin targets despite strong earnings. Analysts remain mixed.

MongoDB's Solid Q4 Overshadowed By Weak FY26 Guidance, Expects Non-Atlas Headwinds

|MDB stock falls despite upbeat Q4 results. Wedbush, RBC, Rosenblatt & Needham maintain Buy ratings but cut price targets due to weaker FY26 guidance.

Marvell Technology Quells Fears Of Losing Next-Gen XPU At Amazon, Expects To Surpass AI Revenues In FY26

|Despite upbeat Q4 results, shares of Marvell Technology Inc (NASDAQ: MRVL) fell due to concerns over losing next-gen XPU at Amazon. Analysts keep Overweight/Buy ratings with price targets ranging from $100-$135.

Best Buy's Comp Sales Turns Positive After 12 Quarters, Heightened Tariff Concerns Weigh On Outlook, Analysts Say

|Shares of Best Buy (BBY) rise after reporting upbeat Q4 sales amid exciting earnings season.

Target Unveils $15 Billion Sales Growth Strategy: Analysts Cut Forecasts, Say Plan Appears Difficult Given Consumer, Tariff Concerns

|Target's sales growth strategy caused a decline in stock value. Analysts have mixed views, with price targets ranging from $122 to $145 and a Buy rating.

CrowdStrike Posts Solid Q4 But Guidance Disappoints, Outage 'Mostly In Rearview Mirror': Analysts

|CrowdStrike reported upbeat Q4 results with ARR up 23% and Flex account value up 92%. Analysts maintain positive outlook.

MongoDB Q4 Preview: In-line Or Marginally Higher Results Expected By Bullish Analyst

|MongoDB Inc (MDB) shares rise ahead of Q4 results, expected to report on March 5. Analyst reaffirms Buy rating and $350 target price.

On Holding Posts Record High Q4 Margins, Analyst Praises Gen Z's 'Sneaker Of Choice'

|On Holding stock rises as company reports strong Q4 sales growth, exceeding expectations. Analyst predicts continued success.

Target Q4 Beats Expectations, Analysts See Profit Pressure Ahead

|Target's (TGT) outlook reflects potential profit pressure in Q1 due to consumer uncertainty and tariffs.

CrowdStrike Q4 Earnings Preview: Analysts Expect Revenue Beat, Even Better Guidance

|CRWD stock rises ahead of fourth quarter results on March 4. Analyst predicts strong revenue and earnings, with focus on NNARR and operating income.

Recursion Pharmaceuticals' Update Could Shed Light On Pipeline, Cost-Saving Plans, Analyst Says

|Recursion Pharmaceuticals is a leader in TechBio with potential to bring in $200M in near-term milestones and $20B in future revenue, according to Needham.

FuboTV Posts Disappointing Q1 Subscriber Guidance, Macro Changes Remain: Analysts

|Shares of FuboTV dropped after reporting Q4 results amid an exciting earnings season. Analysts have mixed outlooks on the company.

Warner Bros Discovery Posts Q4 Miss, Gap With Competitors Is Widening: Analyst

|Warner Bros. revenue growth is likely to be flat, with negative earnings, over the next couple of years, according to Needham.

Bloom Energy Posts Q4 Beat: Margin Profile Remains Below Industry Average, Analyst Says

|Bloom Energy (BE) reported Q4 results ahead of expectations. Analyst Mark Strouse raised price target to $18.

Bath & Body Works Beats Q4, Guidance Disappoints: Analyst Says 2025 Performance Vulnerable To China Tariffs

|Bath & Body Works stock rose slightly after reporting Q4 results. JPMorgan and Telsey maintain buy ratings with price targets of $47 and $43, respectively